Are higher blood eosinophils associated with allergic and food-related immune responses?

Clinical evidence

• Allergic and Atopic Pathology: Elevated peripheral blood eosinophil counts are robust indicators of type-2 (Th2) helper T-cell-mediated immune activation, which is the foundational pathway of classic allergic conditions such as asthma, allergic rhinitis, and atopic dermatitis. In patients with active type-2 disease, blood eosinophil counts often exceed typical reference ranges (typically >300 to 500 cells/µL), reflecting systemic antigen-driven hypersensitivity.
• Food-Related Immune Reactions: Peripheral eosinophilia is frequently observed in individuals experiencing food-related immune pathology. This occurs across both IgE-mediated food allergies (such as acute reactions to milk, eggs, or nuts) and non-IgE-mediated eosinophilic gastrointestinal disorders (EGIDs), including eosinophilic esophagitis (EoE), gastritis, and enteritis. Clinical studies demonstrate that while definitive diagnosis of EGIDs requires tissue biopsy (e.g., mucosal infiltration of ≥15 eosinophils per high-power field in EoE), up to 50% of these patients exhibit concurrent peripheral blood eosinophilia, correlating with disease severity and the presence of multiple food-allergen sensitizations.

Mechanistic explanations

• Th2 Cytokine Cascades: The production, maturation, and systemic circulation of eosinophils are tightly regulated by a distinct cytokine triad: Interleukin-4 (IL-4), Interleukin-13 (IL-13), and Interleukin-5 (IL-5).
• Bone Marrow Mobilization: Upon exposure to an allergen or food antigen, Th2 cells and type 2 innate lymphoid cells (ILC2s) release IL-5. IL-5 acts as the primary lineage-specific cytokine that stimulates the differentiation, maturation, and release of eosinophils from the bone marrow into the bloodstream.
• Chemotaxis and Tissue Homing: Once mobilized into peripheral blood, eosinophils express CCR3 receptors, which respond to local tissue gradients of eotaxins (CCL11, CCL24, CCL26) generated at mucosal surfaces (such as the gut or airway epithelium) exposed to food or environmental antigens. This leads to targeted tissue homing, degranulation, and subsequent localized inflammation.

Bottom line

Higher blood eosinophils are a highly reliable and clinically validated systemic biomarker for Th2-mediated, antigen-driven allergic responses, including IgE-mediated food allergies and eosinophilic gastrointestinal disorders. In a 68-year-old male, elevated peripheral blood eosinophils should prompt a comprehensive clinical evaluation for environmental atopy, drug hypersensitivity, or underlying food-related immune reactions.